BMSSC
NVAX icon

B. Metzler seel. Sohn & Co’s Novavax NVAX Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-1,707
Closed -$264K – 783
2021
Q4 		$264K Buy
1,707
+368
+27% +$63.2K ﹤0.01% 662
2021
Q3 		$278K Buy
1,339
+247
+23% +$54.4K ﹤0.01% 649
2021
Q2 		$232K Buy
+1,092
New +$200K ﹤0.01% 665

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

B. Metzler seel. Sohn & Co's NVAX Position: Q1 2022 in Review

B. Metzler seel. Sohn & Co sold out of Novavax (NVAX) in Q1 2022, closing a stake of 1,707 shares — an estimated $264K sold.

B. Metzler seel. Sohn & Co first reported a position in NVAX in Q2 2021 and held it in 3 quarters. The position peaked at $278K in Q3 2021. 382 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

  • B. Metzler seel. Sohn & Co reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
  • B. Metzler seel. Sohn & Co sold 1,707 Novavax shares in Q1 2022, an estimated $264K.
  • B. Metzler seel. Sohn & Co first reported a position in Novavax in Q2 2021 and held it in 3 quarters.
  • B. Metzler seel. Sohn & Co's Novavax position peaked at $278K in Q3 2021.
  • 382 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q1 2022, filed 10 May 2022.